Abstract
The original ‘product’ of the EQ Group’s efforts was the EuroQol instrument which was designated ‘EQ-5D’ in the mid-1990s. The formal incorporation of the EuroQol Foundation, and the establishment of the Business Management also took place at that time. With this structure in place the possibility to license the instrument arose and some finance was raised. Meanwhile the EQ-5D instrument remained unchanged, leaving the Group with just one ‘product’, with the exception of new language versions of the instrument. As more finances became available the potential to fund research projects and to develop adapted or new EQ-5D products increased. The work of the task forces – the Youth TF (YTF), the Digital TF (DTF), the Condition Specific TF (CSPTF), and the Population Health TF (PHTF) – is detailed to help report upon the more recent developments in the work of the Group.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arons A and Krabbe P. Considering cognition as a bolt-on dimension for the EQ-5D. Paper presented at the 28th Scientific Plenary Meeting of the EuroQol Group, Oxford, September 2011.
Badia X, Roset M, Perulero N. Validation of the EQ-5D to be used in children with persistent asthma. In Pickard (2004).
Brooks R, Rabin R, de Charro F. The Measurement and Valuation of Health Status using EQ-5D: A European Perspective. Kluwer. 2003.
Gusi N, Ortega Y, García-Martin Y, Monge M. Physical activity, lifestyle and health-related quality of life of secondary students in Extremadura, Spain. In Norinder et al (2002).
Hennessy S and Kind P. Measuring health status in children: developing and testing a child-friendly version of EQ-5D. In Kind and Macran (2002).
Jelsma J and Matyida N. The development of an adapted version of the EQ-5D for infants under the age of 36 months. In Prevolnik Rupel (2003).
Jelsma J and Ferguson G. The determinants of HRQoL in able-bodied and disabled children. In de Pouvourville (2009).
Klose, K and Greiner W.: Developing a cognitive dimension as a bolt-on for the EQ-5D-Y in Germany. Poster presented at the 28th Scientific Plenary Meeting, Oxford, UK, September 2011.
Krabbe P, Stouthard M, Esssink-Bot M-L, Bonsel G. The effect of adding a cognitive dimension to the EuroQol multi-attribute health status classification system. Journal of Clinical Epidemiology 1999; 52:293–301.
PJB Publications. SCRIP’s 2000 pharmaceutical companies league tables. PJB Publications 2000.
Ravens-Sieberer U, Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, Egmar A-C, Gusi N, Herdman M, Jelsma J, Kind P, Olivares P, Scalone L, Greiner W. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Quality of Life Research 2010; 19:887–97.
Roset M, Badia X, Benavides A, Herdman M. The validity of the EQ-5D in children with asthma. In Badia et al (2000).
Secnik K, Matza L, Mannix S, Sallee F. Use of the EQ-5D proxy version in a sample of parents who have children diagnosed with attention deficit/ hyperactivity disorder (ADHD). In Prevolnik Rupel (2003).
Secnik, K, Matza, L, Mannix, S.The proxy EQ-5D as a quality of life measure in UK children with attention deficit/ hyperactivity disorder. In Pickard (2004).
Selai C, Gaminde I, Herdman M, Johnson J, Rabin R. EQ-5D: modes of administration. In Brooks et al (2003).
Solem C, Gu N, Pickard AS. Predicting VAS scores by EQ-5D Items and presence of disease: a bolt-on feasibility study. Paper presented at the 28th Scientific Plenary meeting of the EuroQol Group, Oxford, September 2011.
Stavem K. (Ed.) 22nd Plenary Meeting of the EuroQol Group Discussion Papers, Oslo, Norway, September 2005. Helse-Øst Health Services Research Centre, Lørenskog, 2005.
Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, Egmar A-C, Greiner W, Gusi N, Herdman M, Jelsma J, Kind P, Scalone L, Ravens-Sieberer U. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Quality of Life Research 2010; 19:887–97.
Wille N, Hale S, Ravens-Sieberer U, Kohlmann T, Greiner W. Feasibility and preliminary validity of a German EQ-5D childrens version. In Stavem (2005).
Wille N, Ravens-Sieberer U. and the child-friendly task force on behalf of the EuroQol Group. Establishing definitions of the concepts included in CF-EQ-5D: A revision of the “Definition of EQ-5D concepts” for adults. In Badia (2007).
Yang Y et al. The effect of adding a ‘sleep’ dimension to EQ-5D. Paper given at the Health Economists’ Study Group Meeting, January 2008.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Brooks, R. (2012). Research, Product Development, and the Work of the Task Forces. In: The EuroQol Group after 25 years. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5158-3_8
Download citation
DOI: https://doi.org/10.1007/978-94-007-5158-3_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5157-6
Online ISBN: 978-94-007-5158-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)